Taysha Gene Therapies
TSHA
#6865
Rank
โ‚น37.74 B
Marketcap
โ‚น184.19
Share price
8.46%
Change (1 day)
27.01%
Change (1 year)

Taysha Gene Therapies (TSHA) Fails to deliver data

Key failure to deliver metrics for Taysha Gene Therapies:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Taysha Gene Therapies (TSHA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Taysha Gene Therapies (TSHA) - since 2020

Volume in USD (price x number of shares), data since 2020

Taysha Gene Therapies (TSHA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น3.97 M-18.1%
2023โ‚น4.85 M-68.08%
2022โ‚น15.2 M346.84%
2021โ‚น3.4 M-30.11%
2020โ‚น4.86 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น1.5 Mโ‚น5.99 M๐Ÿ‡บ๐Ÿ‡ธ USA